Products

Cannabis-based approved in Brazil

Anvisa has approved the marketing of products extracted from the cannabis plant, cannabidiol (CBD) and tetrahydrocannabinol (THC) for therapeutic purposes, upon presentation of prescription. However, the cultivation of the plant, as well as its use without medical advice, is still prohibited. Several scientific studies show that the cannabis plant contains several active substances with therapeutic

Cannabis-based approved in Brazil Read More »